Immunotherapy associated Sweet syndrome in a patient with metastatic melanoma: A case report

• Autors principals: Rory Barry (Autor), Gregg Murray (Autor), Sally McGrath (Autor), Clive Kilgallen (Autor), Karen Eustace (Autor)
• Format: Llibre
• Publicat: Wiley, 2024-09-01T00:00:00Z.
• Matèries: article
• Accés en línia: Connect to this object online.

Abstract Immunotherapy agents are now widely used in the treatment of metastatic melanoma. Immune‐related adverse events (irAEs) may occur, including cutaneous pathologies in 50% of patients. We report a case of Sweet syndrome (SS) in a patient who was prescribed ipilimumab and nivolumab for metasta...